Real-time enrollment status for this pancreas adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 11:58 PM UTC
| NCT Number | NCT07043270 |
| Recruiting Status | Recruiting |
| Condition | Pancreas Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 35 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Dartmouth-Hitchcock Medical Center |
| Last Updated on CT.gov | October 20, 2025 (Oct 20, 2025) |
As of July 22, 2026: Clinical trial NCT07043270 is currently recruiting participants. This phase2 study for pancreas adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Dartmouth-Hitchcock Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07043270 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07043270 was last updated Oct 20, 2025 (October 20, 2025). HelloStudys verifies this status automatically.